- ￥2588 - 9188
- abinScience
- France
- MV612010
- 2025年07月12日
- FuncS
- Mouse
- Mouse
企业认证
相关产品推荐更多 >
](https://img1.dxycdn.com/p/s14/2025/0313/728/8231736460229510091.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG2a-kappa
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
Mouse
- 保质期：
12 months
- 级别：
一抗
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Mouse
- 应用范围：
FuncS
- 浓度：
0.22 mg/ml
- 抗体英文名：
InVivoMAb Anti-Mouse CD276/B7-H3 & CD3E Bispecific Antibody
- 规格：
100μg/1mg
| 规格： | 100μg | 产品价格： | ￥2588.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| Product name | InVivoMAb Anti-Mouse CD276/B7-H3 & CD3E Bispecific Antibody |
| Catalog No. | MV612010 |
| Target | CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| Clonality | Monoclonal |
| Host species | Mouse |
| Species reactivity | Mouse |
| Applications | FuncS |
| Isotype | IgG2a-kappa |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Concentration | 0.22 mg/ml |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Purified by Nickel column. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验How to Make Bispecific Antibodies
of two molecules of Fab’-A(mal) with two free SH-groups at the hinge of a single Fab’-B molecule (see Note 3 ). The remaining free SH groups on Fab’-B are alkylated, and the F(ab’)2 bispecific antibody product (Fab’-A x Fab’-B) is separated by gel filtration
[欢迎下载]：Antibody Engineering： Methods and Protocols
11 Selection of Internalizing Antibodies for Drug Delivery 12 Engineering Multivalent Antibody Fragments for In Vivo Targeting 13 Production of Recombinant Bispecific Antibodies 14 Expression and Isolation of Recombinant Antibody Fragments in E
【翻译】Development trends for monoclonal antibody cancer therapeutics
, after binding to a target, mAbs can recruit effector cells such as natural killer cells, macrophages or neutrophils, or activate complement to destroy the target3, 24, 25, 26, 27. These two modes of action are referred to as antibody-dependent cell cytotoxicity
技术资料暂无技术资料 索取技术资料
